INOTUZUMAB OZOGAMICIN
UNII P93RUU11P7

Substance Identification & Data

This profile provides standardized clinical and technical data for Inotuzumab Ozogamicin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) P93RUU11P7.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 635715-01-4 and the RxNorm Concept ID (RxCUI) 1942950. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

P93RUU11P7

CAS Registry Number

635715-01-4

RxNorm Concept ID

1942950

Detailed Substance Profile

Preferred Name

INOTUZUMAB OZOGAMICIN

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

P93RUU11P7

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C71542

National Cancer Institute reference terminology for clinical and research data.

INN ID

8574

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

QQ-54

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Inotuzumab Ozogamicin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

INOTUZUMAB OZOGAMICIN

Common Names & Synonyms

IMMUNOGLOBULIN G4 (ANTI-(HUMAN CD22 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL G544 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL G544 .KAPPA.-CHAIN, DIMER, METHYL ((1R,4Z,8S,13E)-8-((2-O-(4-(ACETYLETHYLAMINO)-2,4-DIDEOXY-3-O-METHYL-.ALPHA.-L-THREO-PENTOPYRANOSYL)-4,6-DIDEOXY-4-(((2,6-DIDEOXY-4-S-(4-((6-DEOXY-3-O-METHYL-.ALPHA.-L-MANNOPYRANOSYL)OXY)-3-IODO-5,6-DIMETHOXY-2-METHYLBENZOYL)-4-THIO-.BETA.-D-RIBO-HEXOPYRANOSYL)OXY)AMINO)-.BETA.-D-GLUCOPYRANOSYL)OXY)-13-(2-((3-((1-(4-(4-AMINO-4-OXOBUTOXY)PHENYL)ETHYLIDENE)HYDRAZINO)-1,1-DIMETHYL-3-OXOPROPYL)DITHIO)ETHYLIDENE)-1-HYDROXY-11-OXOBICYCLO(7.3.1)TRIDECA-4,9-DIENE-2,6-DIYN-10-YL)CARBAMATE CONJUGATE

INOTUZUMAB OZOGAMICIN [INN]

INOTUZUMAB OZOGAMICIN [JAN]

INOTUZUMAB OZOGAMICIN [MART.]

INOTUZUMAB OZOGAMICIN [MI]

INOTUZUMAB OZOGAMICIN [PURPLE BOOK CDER]

INOTUZUMAB OZOGAMICIN [USAN]

INOTUZUMAB OZOGAMICIN [WHO-DD]